Literature DB >> 3342483

The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks.

K Gotoh1, T Minamino, O Katoh, Y Hamano, S Fukui, M Hori, H Kusuoka, M Mishima, M Inoue, T Kamada.   

Abstract

Intracoronary thrombus is regarded as a potentially important factor in the etiology of unstable angina, but the incidence of intracoronary thrombus in unstable angina has not been clearly defined. To determine the occurrence of intracoronary thrombus during ongoing angina pectoris, coronary angiography was performed during spontaneous ischemic attacks in 37 patients with prolonged rest angina. All patients exhibited significant (greater than 50%) stenoses of at least one major coronary artery. Of the 37 patients, 21 (57%) had intracoronary thrombus in major coronary arteries, whereas 14 (38%) had fixed narrowings without evidence of intracoronary thrombus and two exhibited coronary spasm. ST segment elevation was observed in 16 of 21 patients with thrombus and in all of the patients with coronary spasm, but all the patients with organic stable obstruction showed ST segment depression. Twenty of the 21 patients with thrombus improved after thrombolytic therapy with intracoronary injection of urokinase; obstructed arteries were reopened, or narrowings were attenuated, with relief of ischemic symptoms. In patients with fixed obstructions, the rate-pressure product during active symptoms was significantly higher than during an asymptomatic period, indicating that a transient increase in myocardial oxygen demand may contribute to the ischemic attack in these patients. A high incidence (71%) of recurrent symptoms was observed in patients with intracoronary thrombus even after successful thrombolysis, in contrast to a much lower incidence (36%) in those without intracoronary thrombus. Myocardial infarction within 4 weeks after catheterization was observed more frequently in patients with intracoronary thrombus (24%) than in those without thrombus (7%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342483     DOI: 10.1161/01.cir.77.3.526

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

Review 1.  The management of thrombotic lesions in the cardiac catheterization laboratory.

Authors:  Fadi Matar; Jad Mroue
Journal:  J Cardiovasc Transl Res       Date:  2011-10-21       Impact factor: 4.132

Review 2.  Recognition and treatment of unstable angina.

Authors:  C Brunelli; P Spallarossa; P Rossettin; S Caponnetto
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 3.  Vessel wall-related risk factors in acute vascular events.

Authors:  L Badimon; J J Badimon; M Cohen; J H Chesebro; V Fuster
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 4.  Therapeutic options in treating acute myocardial infarction.

Authors:  J W Danforth
Journal:  West J Med       Date:  1989-10

5.  Comparison of the clinical and morphologic characteristics of culprit lesions in unstable angina and non-ST-elevation myocardial infarction.

Authors:  Reza Kiani; Hamid Reza Sanati; Seifollah Abdi; Farshad Shakerian; Ata Firoozi; Ali Zahedmehr
Journal:  Heart Asia       Date:  2012-01-01

Review 6.  Acute coronary events.

Authors:  Armin Arbab-Zadeh; Masataka Nakano; Renu Virmani; Valentin Fuster
Journal:  Circulation       Date:  2012-03-06       Impact factor: 29.690

7.  Correlation between clinical course and quantitative analysis of the ischemia related artery in patients with unstable angina pectoris, refractory to medical treatment. Results of two randomized trials. The European Cooperative Study Group.

Authors:  M J van den Brand; A van Miltenburg; M J de Boer; L R van der Wieken; P J de Feyter; M L Simoons
Journal:  Int J Card Imaging       Date:  1994-09

8.  Early remodelling of coronary stenoses after thrombolytic treatment in patients with acute myocardial infarction.

Authors:  D Tousoulis; F Andreotti; D Hackett; A W Haider; A Maseri; G Davies
Journal:  Br Heart J       Date:  1995-09

9.  Eptifibatide: The evidence for its role in the management of acute coronary syndromes.

Authors:  Ibrahim Shah; Shakeel O Khan; Surender Malhotra; Tim Fischell
Journal:  Core Evid       Date:  2010-06-15

10.  Clinician update: direct thrombin inhibitors in acute coronary syndromes.

Authors:  Joanna J Wykrzykowska; Sekar Kathiresan; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.